AP
AXDX

Advisors Preferred’s Accelerate Diagnostics AXDX Stock Holding History

Advisors Preferred’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-53
Closed -$6K – 345
2013
Q4 		$6K Buy
+53
New +$7.08K ﹤0.01% 339

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisors Preferred's AXDX Position: Q1 2014 in Review

Advisors Preferred sold out of Accelerate Diagnostics (AXDX) in Q1 2014, closing a stake of 53 shares — an estimated $6K sold.

Advisors Preferred first reported a position in AXDX in Q4 2013 and held it in 1 quarter. The position peaked at $6K in Q4 2013. 56 funds tracked by Wall St. Rank hold AXDX as of Q1 2014.

  • Advisors Preferred reported no remaining Accelerate Diagnostics position as of Q1 2014 after selling out during the quarter.
  • Advisors Preferred sold 53 Accelerate Diagnostics shares in Q1 2014, an estimated $6K.
  • Advisors Preferred first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 1 quarter.
  • Advisors Preferred's Accelerate Diagnostics position peaked at $6K in Q4 2013.
  • 56 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2014.

Based on Advisors Preferred's 13F filing for Q1 2014, filed 14 May 2014.